Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The findings in the chronic model indicated that EGCG treatment effectively reduced food intake, body weight gain, and adiposity. Additionally, the supplement exhibited anti-inflammatory effects and increased muscle area, mimicking the beneficial effects of physical exercise
Key Takeaways Starting dose: 2 mg once weekly for 4 weeks Titration pace: Increase every 4 weeks: 2 4 8 12 mg Maximum dose: 12 mg weekly (Phase 2/3 clinical trial protocol) Total ramp-up: ~16 weeks to reach maximum dose Mechanism: Triple agonist (GLP-1 + GIP + Glucagon), the only triple-agonist in late-stage trials Weight loss: Up to 24.2% at 48 weeks (Phase 2) and 28.7% at 68 weeks (Phase 3 TRIUMPH-4) GLP-3 Retatrutide Dosage Chart Free printable reference chart showing the retatrutide (GLP-3) clinical trial titration schedule from 2 mg to 12 mg weekly
It can: Get you moving Make the process easier Build initial momentum But eventually, those training wheels come off
Signs of degradation Check the solution before every draw
We have not observed any difference in the rate of acute pancreatitis or gastrointestinal disturbance associated with GLP-1 RA compared to SGLT2i therapy and patients with type 1 diabetes
US$ 22.20
US$ 25.22
US$ 20.64
US$ 20.70
US$ 21.97
US$ 26.65
US$ 22.20
US$ 22.11
